Detection of BCR-ABL T315I mutation by peptide nucleic acid directed PCR clamping and by peptide nucleic acid FISH

被引：9

作者：

Rosso V. ^{[1
]}

Bracco E. ^{[2
]}

Pedrola R. ^{[1
]}

Carturan S. ^{[1
]}

Signorino E. ^{[1
]}

Petiti J. ^{[1
]}

Calabrese C. ^{[1
]}

Nicoli P. ^{[1
]}

De Gobbi M. ^{[1
]}

Gaidano V. ^{[1
]}

Gallo D. ^{[1
]}

Ulisciani S. ^{[1
]}

Fava C. ^{[1
]}

Rege-Cambrin G. ^{[1
]}

Frassoni F. ^{[3
]}

Saglio G. ^{[1
]}

Cilloni D. ^{[1
]}

机构：

[1] Department of Clinical and Biological Sciences, University of Turin, Turin

[2] Department of Oncology, University of Turin, Turin

[3] Department of Pediatric Hemato-Oncology and Stem Cell and Cellular Therapy Laboratory, Institute G. Gaslini, Largo G Gaslini, Genoa

来源：

Biomarker Research | / 3卷 / 1期

关键词：

BCR-ABL1; Chronic Myeloid Leukemia; PNA; T315I mutation;

D O I：

10.1186/s40364-015-0039-y

中图分类号：

学科分类号：

摘要：

Background: Mutations of the BCR-ABL1 fusion gene represent a well established cause of resistance to tyrosine kinase inhibitors. Among the different mutations identified T315I is of particular concern since it is not effectively targeted by the majority of Tyrosine Kinase Inhibitors so far available. We developed a novel assay based on peptide nucleic acid (PNA) technology coupled to immunofluorescence microscopy (PNA-FISH) for the specific detection at a single cell level of BCR-ABL T315I mutation thus improving both, diagnostic resolution and the study of clonal prevalence. Furthermore we developed an additional method based on PNA directed PCR-clamping for the fast and easy detection of the mutation. Results: The PNA directed PCR clamping allows to detect an amount of mutated template as low as 0.5 %. This method is highly sensitive, specific and cheap and could be applied even in laboratory not equipped for more sophisticated analysis. Furthermore, the PNA FISH method allows to identify a small amount of progenitor cells still present after therapy with specific inhibitors. Conclusions: We present here two different methods based on PNA for the detection of T315I useful for different purposes. PNA-FISH can be used to study clonal evolution. In addition, this method could help in the study of compound mutations being able to identify two different mutations in a single cell. PNA directed PCR clamping although not superior to sequencing can be applied worldwide even in laboratory not equipped to search for mutations. © 2015 Rosso et al.

引用

共 11 条

[1]

Groffen J., Stephenson J.R., Heisterkamp N., De Klein A., Bartram C.R., Grosveld G., Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22, Cell, 36, pp. 93-99, (1984)

[2]

Soverini S., Hochhaus A., Nicolini F.E., Gruber F., Lange T., Saglio G., Et al., BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Recommendations from an expert panel on behalf of European LeukemiaNet, Blood, 118, pp. 1208-1215, (2011)

[3]

Hughes T., Saglio G., Branford S., Soverini S., Kim D.W., Muller M.C., Et al., Impact of baseline BCR-ABL mutations on response to nilotinib in patients with chronic myeloid leukemia in chronic phase, J Clin Oncol, 27, pp. 4204-4210, (2009)

[4]

Cortes J.E., Kim D.W., Pinilla-Ibarz J., Le Coutre P., Paquette R., Chuah C., Et al., Kantarjian H A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias, N Engl J Med, 369, pp. 1783-1796, (2013)

[5]

Quintas-Cardama A., Gibbons D.L., Kantarjian H., Talpaz M., Donato N., Cortes J., Sequencing of subcloned PCR products facilitates earlier detection of BCR-ABL1 (T315I) and other mutants compared to direct sequencing of the ABL1 kinase domain, Leukemia, 22, pp. 885-888, (2008)

[6]

Preuner S., Mitterbauer G., Mannhalter C., Herndlhofer S., Sperr W.R., Valent P., Et al., Quantitative monitoring of BCR/ABL1 mutants for surveillance of subclone-evolution, expansion, and depletion in chronic myeloid leukaemia, Eur J Cancer, 48, pp. 233-236, (2012)

[7]

Soverini S., De Benedittis C., Machova Polakova K., Brouckova A., Horner D., Iacono M., Et al., Unraveling the complexity of tyrosine kinase inhibitor-resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain, Blood, 122, pp. 1634-1648, (2013)

[8]

Sugimoto N., Yamamoto K., Satoh N., Positional effect of single bulge nucleotide on PNA (peptide nucleic acid)/DNA hybrid stability, Nucleic Acids Symp Ser, 42, pp. 95-96, (1999)

[9]

Sugimoto N., Satoh N., Yamamoto K., Comparison of thermodynamic stabilities between PNA (peptide nucleic acid)/DNA hybrid duplexes and DNA/DNA duplexes, Nucleic Acids Symp Ser, 42, pp. 93-94, (1999)

[10]

Bracco E., Rosso V., Serra A., Carnuccio F., Gaidano V., Nicoli P., Et al., Design and application of a novel PNA probe for the detection at single cell level of JAK2V617F mutation in Myeloproliferative Neoplasms, BMC Cancer, 13, (2013)

← 1 2 →